Elizabeth Douglass is an Infectious Disease physician affiliated with The University of Texas at Austin. OpenAlex indexes 12 publications with 227 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
313 E 12th St Ste 102
Austin, TX 787011955
Telephone
409-772-2222Registry record last updated 14 Dec 2012.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Cumberland Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
85.2%Penicillins with extended spectrum18.8%Amoxicillin74%Amoxicillin-Clavulanate Potass26%Part D<11 patientsHuman Immunodeficiency Virus Integrase Strand Transfer Inhibitor14.5%Dovato61%Tivicay39%Part D<11 patients+ 7 more classes in this area
Sensory organs
11.8%Fluoroquinolone Antibacterial11.8%Ciprofloxacin Hcl100%Part D<11 patientsCardiovascular
3%Statin3%Atorvastatin Calcium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Rethinking Carbapenems: A Pharmacokinetic Approach for Antimicrobial Selection in Infected Necrotizing Pancreatitis
Annals of Pharmacotherapy
2020 - A Case of Murine Typhus Presenting With Hemophagocytic Lymphohistiocytosis
Infectious Diseases in Clinical Practice
2019 - Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection
Antimicrobial Agents and Chemotherapy
2017 - Treatment of<i>Mycobacterium abscessus</i>subsp.<i>massiliense</i>Tricuspid Valve Endocarditis
Emerging infectious diseases
2015
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Warach, MD, PhD
The University of Texas at Austin
Elizabeth Matsui, MD
The University of Texas at Austin
Jorge Almeida, MD
The University of Texas at Austin
George Rodgers, MD
The University of Texas at Austin
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”